Thermo Fisher Scientific
TMO
2,131 hedge funds and large institutions have $198B invested in Thermo Fisher Scientific in 2021 Q3 according to their latest regulatory filings, with 163 funds opening new positions, 803 increasing their positions, 808 reducing their positions, and 80 closing their positions.
104% more first-time investments, than exits
New positions opened: 163 | Existing positions closed: 80
39% more funds holding in top 10
Funds holding in top 10: 155 → 215 (+60)
14% more capital invested
Capital invested by funds: $173B → $198B (+$24.4B)
3% more funds holding
Funds holding: 2,077 → 2,131 (+54)
0.51% more ownership
Funds ownership: 87.35% → 87.87% (+0.51%)
1% less repeat investments, than reductions
Existing positions increased: 803 | Existing positions reduced: 808
24% less call options, than puts
Call options by funds: $1.56B | Put options by funds: $2.05B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$703M |
| 2 |
BlackRock
New York
|
+$504M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$245M |
| 4 |
RI
RTW Investments
New York
|
+$228M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$179M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$517M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$455M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$252M |
| 4 |
SG Americas Securities
New York
|
-$249M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$200M |
TMO Hedge Fund Activity: Q3 2021 in Review
2,131 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2021, worth a combined $198B — up 14% from $173B a quarter earlier.
Buyers outnumbered sellers: 163 funds opened new TMO positions and 80 closed out — a net gain of 83 holders — while 803 added to existing stakes and 808 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $517M.
- 2,131 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2021, up from 2,077 in Q2 2021.
- Funds reported $198B of Thermo Fisher Scientific stock for Q3 2021, up 14% quarter-over-quarter.
- 163 funds opened new Thermo Fisher Scientific positions in Q3 2021 and 80 closed out, a net change of +83 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2021 was Fidelity Investments, an estimated $703M added.
- The largest Thermo Fisher Scientific seller in Q3 2021 was Wellington Management Group, an estimated $517M sold.
Based on aggregated 13F filings for Q3 2021.